Does a retzius-sparing surgical technique improve urinary continence recovery after a robot-assisted laparoscopic radical prostatectomy: results of a systematic review and meta-analysis of comparative studies.

Autor: Yaxley JW; The Wesley Hospital, Brisbane, QLD, Australia. john@wesleyurologyclinic.com.au.; The University of Queensland, Faculty of Medicine, Brisbane, QLD, Australia. john@wesleyurologyclinic.com.au.; Royal Brisbane and Women's Hospital, Department of Urology, Brisbane, QLD, Australia. john@wesleyurologyclinic.com.au., Gianduzzo T; The Wesley Hospital, Brisbane, QLD, Australia.; The University of Queensland, Faculty of Medicine, Brisbane, QLD, Australia.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.

Autor: Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Papa N; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Veerman H; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., de Bie K; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Morton A; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Franklin A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Raveenthiran S; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Yaxley WJ; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Donswijk ML; Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Samaratunga H; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Pathology, Aquesta Uropathology, Brisbane, Queensland, Australia., Wong D; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., Brown N; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., Parkinson R; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., Gianduzzo T; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Kua B; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Coughlin GD; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Emmett L; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia., van Leeuwen PJ; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Yaxley JW; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Vis AN; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.

Publikováno v: BJU international [BJU Int] 2024 Sep 11. Date of Electronic Publication: 2024 Sep 11.

The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort.

Autor: Tariq A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia., Pearce A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Australia., Rhee H; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Department of Urology, Princess Alexandra Hospital, Brisbane, Australia., Kyle S; Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Australia; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia., Raveenthiran S; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Department of Urology, Redcliffe Hospital, Redcliffe, Australia., Pelecanos A; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Gan CL; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia., Goh JC; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia., Wong D; Department of Radiology & Nuclear Medicine, The Wesley Hospital, Brisbane, Australia., McBean R; Department of Radiology & Nuclear Medicine, The Wesley Hospital, Brisbane, Australia., Marsh P; Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Australia., Goodman S; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia., Dunglison N; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia., Esler R; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Australia., Navaratnam A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia., Yaxley JW; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Australia., Thomas P; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia., Pattison DA; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia., Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia; Department of Urology, Redcliffe Hospital, Redcliffe, Australia; UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Brisbane, Australia. Electronic address: m.roberts2@uq.edu.au.

Publikováno v: European urology focus [Eur Urol Focus] 2024 Jan 08. Date of Electronic Publication: 2024 Jan 08.

Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.

Autor: Vis AN; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands; Department of Urology, Prostate Cancer Network Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Meijer D; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands; Department of Urology, Prostate Cancer Network Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands. Electronic address: d.meijer2@amsterdamumc.nl., Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; University of Queensland Centre for Clinical Research, Herston, Australia; Department of Urology, Redcliffe Hospital, Brisbane, Australia., Siriwardana AR; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia., Morton A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, University of Queensland, Brisbane, Australia., Yaxley JW; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; Faculty of Medicine, University of Queensland, Brisbane, Australia; Department of Urology, Wesley Hospital, Brisbane, Australia., Samaratunga H; Faculty of Medicine, University of Queensland, Brisbane, Australia; Department of Pathology, Aquesta Uropathology, Brisbane, Australia., Emmett L; St. Vincent's Clinical School, University of New South Wales, Kensington, Australia; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital Sydney, Darlinghurst, Australia., van de Ven PM; Department of Epidemiology and Data Science, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands., Heymans MW; Department of Epidemiology and Data Science, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands., Nieuwenhuijzen JA; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands; Department of Urology, Prostate Cancer Network Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands; Department of Urology, Prostate Cancer Network Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Boellaard TN; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schoots IG; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands., Stricker P; St Vincent's Clinic, St. Vincent's Prostate Cancer Centre, Sydney, Australia; Australian Prostate Cancer Research Centre - New South Wales, The Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Sydney, Australia., Haynes AM; Australian Prostate Cancer Research Centre - New South Wales, The Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Sydney, Australia., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands., Coughlin GD; Faculty of Medicine, University of Queensland, Brisbane, Australia; Department of Urology, Wesley Hospital, Brisbane, Australia., van Leeuwen PJ; Department of Urology, Prostate Cancer Network Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publikováno v: European urology oncology [Eur Urol Oncol] 2023 Dec; Vol. 6 (6), pp. 553-563. Date of Electronic Publication: 2023 Apr 10.

Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?

Autor: Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia., Hruby G; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Genesis Cancer Care, Sydney, New South Wales, Australia., Kneebone A; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Genesis Cancer Care, Sydney, New South Wales, Australia., Martin JM; Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, New South Wales, Australia.; Genesis Care, Maitland, Metford, New South Wales, Australia., Williams SG; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia.; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Frydenberg M; Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.; Cabrini Research, Cabrini Health, Melbourne, Victoria, Australia., Murphy DG; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia.; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Namdarian B; St Vincent's Hospital, Darlinghurst, Sydney, New South Wales, Australia., Yaxley JW; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia., Hofman MS; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia.; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Victoria, Melbourne, Australia., Davis ID; Eastern Health Clinical School, Monash University, Victoria, Melbourne, Australia.; Department of Cancer Services, Eastern Health, Melbourne, Victoria, Australia., Emmett L; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Publikováno v: BJU international [BJU Int] 2023 Aug; Vol. 132 (2), pp. 146-148. Date of Electronic Publication: 2023 Jun 11.